17 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33910844 | Intravenous Iron Replacement Therapy Improves Cardiovascular Outcomes in Hemodialysis Patients. | 2021 May-Jun | 1 |
2 | 33918110 | Efficacy and Safety of Intravenous Ferric Carboxymaltose in Patients with Postoperative Anemia Following Same-Day Bilateral Total Knee Arthroplasty: A Randomized Controlled Trial. | 2021 Apr 2 | 1 |
3 | 34079413 | Ferric Carboxymaltose for Anemic Perioperative Populations: A Systematic Literature Review of Randomized Controlled Trials. | 2021 | 1 |
4 | 34470831 | Comparison of Iron Dosing Strategies in Patients Undergoing Long-Term Hemodialysis: A Randomized Controlled Trial. | 2021 Oct | 1 |
5 | 31561177 | The Effect of Perioperative Intravenous Iron on Hemoglobin in Surgical Patients: A Meta-Analysis. | 2020 Feb | 1 |
6 | 31937462 | Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Ferric Carboxymaltose in Chinese Patients with Iron-deficiency Anemia. | 2020 Feb | 1 |
7 | 32154642 | Intravenous ferric carboxymaltose for iron deficiency anemia in dialysis patients: Effect of a new protocol adopted for a hemodialysis limited assistance center. | 2020 Dec | 1 |
8 | 32839355 | Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: Reduction of erythropoietin dose in 4 years of follow-up. | 2020 Sep 30 | 2 |
9 | 31197861 | Randomised clinical trial: intravenous vs oral iron for the treatment of anaemia after acute gastrointestinal bleeding. | 2019 Aug | 1 |
10 | 28701470 | Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency. | 2017 Oct 10 | 1 |
11 | 27282576 | Assessment of serum bioactive hepcidin-25, soluble transferrin receptor and their ratio in predialysis patients: Correlation with the response to intravenous ferric carboxymaltose. | 2016 Jul | 1 |
12 | 25326244 | Iron sucrose and ferric carboxymaltose: no correlation between physicochemical stability and biological activity. | 2015 Feb | 2 |
13 | 23071262 | Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia. | 2013 Feb | 1 |
14 | 23078888 | Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. | 2013 Mar | 2 |
15 | 21942989 | Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data. | 2011 Sep 24 | 2 |
16 | 20648930 | Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications. | 2010 | 1 |
17 | 19405553 | Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. | 2009 | 4 |